Ethanol extract of Portulaca oleracea L. protects against hypoxia-induced neuro damage through modulating endogenous erythropoietin expression

Journal of Nutritional Biochemistry

Volumn 23, Issue 4, 2012, Pages 385-391

  Wanyin, Wang ^a   Liwei, Dong ^a   Lin, Jia ^a   Hailiang, Xin ^b   Changquan, Ling ^b   Min, Li ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Erythropoietin; Ethanol extract; Hypoxia; Hypoxia inducible factor 1 (HIF 1); Portulaca oleracea L. (EEPO)

Indexed keywords

CASPASE 3; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; NEURON SPECIFIC ENOLASE; PORTULACA OLERACEA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOXIA; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; ANOXIA; CASPASE 3; CELLS, CULTURED; ERYTHROPOIESIS; ERYTHROPOIETIN; ETHANOL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HYPOXIA-ISCHEMIA, BRAIN; MICE; MICE, INBRED ICR; NEURONS; NEUROPROTECTIVE AGENTS; PLANT EXTRACTS; PORTULACA; RECEPTORS, ERYTHROPOIETIN;

MUS; PORTULACA OLERACEA;

EID: 84858291059     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.12.015     Document Type: Article

References (44)

1. Kangae L., Robert A.R., John J.L. Hypoxia, drug therapy and toxicity. Pharmacol Ther 2007, 113:229-246.
2. Pulsinelli W.A. Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res 1985, 63:29-37.
3. Naranda T., Wong K., Kaufman R.I., Goldstein A., Olsson L. Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site. Proc Natl Acad Sci U S A 1999, 96:7569-7574.
4. Morishita E., Masuda S., Nagao M., Yasuda Y., Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997, 76(1):105-116.
5. Jelkmann W. Molecular biology of erythropoietin. Intern Med 2004, 43:649-659.
6. Marti H.H. Erythropoietin and the hypoxic brain. J Exp Biol 2004, 207(Pt 18):3233-3242.
7. Constance T.N., Pundit A., Teng R.F., Jia Y. Role of erythropoietin in the brain. Crit Rev Oncol/Hematol 2007, 64:159-171.
8. Cotena S., Piazza O., Tufano R. The use of erythropoietin in cerebral diseases. Panminerva Med 2008, 50(2):185-192.
9. Ehrenreich H., Weissenborn K., Prange H., Schneider D., Weimar C., Wartenberg K., et al. Recombinant human erythropoietin in the treatment of acute ischemic Stroke. Stroke 2009, 40:e647-e656.
10. Minnerup J., Wersching H., Schäbitz W.R. EPO for stroke therapy - is there a future for further clinical development?. Exp Transl Stroke Med 2010, 2:10.
11. Hu L.F., Xu X.Y., Wang B.Q. Research and utilization situation of Portulaca Oleracea L. in China. Prac J Med Pharm 2003, 20:315-316.
12. Xiang L., Xing D., Wang W., Wang R., Ding Y., Du L. Alkaloids from Portulaca oleracea L. Phytochemistry 2005, 66(21):2595-2601.
13. Miller A.G., Morris M. Plants of Dhofa, the Southern region of Oman. Traditional, economical and medicinal uses 1988.
14. Ghazanfar S.A. Handbook of Arabian medicinal plants 1994, 176. CRC Press, Boca Raton, FL.
15. Rashed A.N., Afifi F.U., Disi A.M. Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J Ethnopharmacol 2003, 88:131-136.
16. Zhang X.J., Ji Y.B., Qu Z.h.Y., Xia J.C.h., Wang L. Experimental studies on antibiotic functions of Portulaca oleracea L. in vitro. Chinese J Microecol 2002, 14:277-280.
17. Zhang H.X., Yu N.C., Huang G.F., Shao J.B., Wu Y.X., Huang H.J., et al. Neuroprotective effects of purslane herb aqueous extracts against d-galactose induced neurotoxicity. Chem-Biol Interact 2007, 170:145-152.
18. Wang W.Y., Gu L.M., Wang X., Dong L.W., Huang X.Q., Li M. Protective effect of Portulaca oleracea extracts on hypoxic nerve tissue and its mechanism. Asia Pac J Clin Nutr 2007, 16(Suppl 1):227-233.
19. Chen C.h.J., Wang W.Y., Wang X.L., Dong L.W., Yue Y.T., Xin H.L., et al. Anti-hypoxic activity of the ethanol extract from Portulaca oleracea in mice. J Ethnopharmacol 2009, 124:246-250.
20. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 2002, 22:10291-10301.
21. Chen J., Shi Y.P., Liu J.Y. Determination of noradrenaline and dopamine in Chinese herbal extracts from Portulaca oleracea L. by high-performance liquid chromatography. J Chromatogr A 2003, 1003:127-132.
22. Jian J.W., Xiao Q.X. Phytomedicine effective component book 1986, People's Hygiene Press, Beijing.
23. Xu X.Q., Yu L.S., Chen G.N. Determination of flavonoids in Portulaca oleracea L. by capillary electrophoresis with electrochemical detection. J Pharm Biomed Anal 2006, 41:493-499.
24. Swamy M., Salleh M.J., Sirajudeen K.N., Yusof W.R., Chandran G. Nitric oxide (no), citrulline-no cycle enzymes, glutamine synthetase and oxidative stress in anoxia (hypobaric hypoxia) and reperfusion in rat brain. Int J Med Sci 2010, 7(3):147-154.
25. Zhu L., Wu X.M., Yang L., Du F., Qian Z.M. Up-regulation of HIF-1alpha expression induced by ginkgolides in hypoxic neurons. Brain Res 2007, 1166:1-8.
26. Qian L.B., Wang H.P., Chen Y., Chen F.X., Ma Y.Y., Bruce I.C., et al. Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress. Pharmacol Res 2010, 61(4):281-287.
27. Wang G.L., Semenza G.L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 1993, 90:4304-4308.
28. Giordano F.J., Johnson R.S. Angiogenesis: the role of the microenvironment in flipping the switch. Curr Opin Genet Dev 2001, 11(1):35-40.
29. Semenza G.L. Involvement of hypoxia-inducible factor 1 in human cancer. Intern Med 2002, 41(2):79-83.
30. Mukhopadhyay C.K., Mazumder B., Fox P.L. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. Biol Chem 2000, 275(28):21048-21054.
31. Lu H., Forbes R.A., Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 2002, 277(26):23111-23115.
32. Krishnamachary B., Berg-Dixon S., Kelly B., Agani F., Feldser D., Ferreira G., et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003, 63(5):1138-1143.
33. Wenger R.H. Mammalian oxygen sensing, signal and gene regulation. J Exp Biol 2000, 203:1253-1263.
34. Semenza G.L., Nejfelt M.K., Chi S.M., Antonarakis S.E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc Natl Acad Sci U S A 1991, 88(13):5680-5684.
35. Marti H.H., Wenger R.H., Rivas L.A., Straumann U., Digicaylioglu M., Henn V., et al. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 1996, 8:666-676.
36. Digicaylioglu M., Bichet S., Marti H.H., Wenger R.H., Rivas L.A., Bauer C., et al. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci U S A 1995, 92:3717-3720.
37. Michael A., Kooij V.D., Groenendaal F., Kavelaars A., Heijnen C.J., Bel F.V. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia. Brain Res Rev 2008, 4:22-33.
38. Liu J., Narasimhan P., Yu F., Chan P.H. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia inducible factor and erythropoietin. Stroke 2005, 36:1264-1269.
39. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995, 92:5510-5514.
40. Huang Z.J., Ederry I., Rosbash M. PAS is a dimerization domain common to drosophila period and several transcription factors. Nature 1993, 364:259-262.
41. Semenza G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999, 15:551-578.
42. Salceda S., Caro J. Hypoxia-inducible factor 1α (HIF1-α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 1997, 27:222642-222647.
43. Jelkmann W., Wagner K. Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann Hematol 2004, 83(11):673-686.
44. Giaccia A., Siim B.G., Johnson R.S. HIF-1 as a target for drug development. Nat Rev 2003, 2:1-9.